<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="32485" whole_study_id="32485" phs="002131" v="1" p="1" createDate="2018-11-29T23:54:54-05:00" completedByGPADate="2018-12-01T15:32:09-05:00" modDate="2020-10-23T15:54:56-05:00" maxParentChildStudyModDate="2020-10-23T15:54:56-05:00" num_participants="38"><StudyInfo accession="phs002131.v1.p1" parentAccession="phs002131.v1.p1"><BioProject id="PRJNA671376" entrez_id="671376" type="bp_admin_access"/><BioProject id="PRJNA671377" entrez_id="671377" type="bp_data_submission"/><StudyNameEntrez>Dynamics of Tumor and Immune Responses During Immune Checkpoint Blockade in Non-Small Cell Lung Cancer</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="somatic_snv"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>dna</StudyType><StudyType>somatic_snv</StudyType><StudyType>targeted_exome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="VANAGNO1" aid="2" auth="eRA" login="VANAGNO1" fname="Valsamo" mname="" lname="Anagnostou" email="vanagno1@jhmi.edu"><Role allow_direct_access="true">PI</Role><Organization>JOHNS HOPKINS UNIVERSITY</Organization></Person><Person nedid="0013287249" aid="1" auth="cit" login="ossandom" fname="Miguel" mname="R" lname="Ossandon" email="ossandom@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person aid="8" auth="virtual" fname="Daniel" lname="Bruhm" email="dbruhm1@jhmi.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0014159529" aid="1" auth="cit" login="waltont" fname="Tamara" mname="Bene" lname="Walton" email="waltont@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>This work was supported in part by US National Institutes of Health grants CA121113 (V.Velculescu, V. Anagnostou), CA006973 (D. Pardoll, V. Velculescu), CA180950 (V. Velculescu), the Commonwealth Foundation (V. Velculescu), the Bloomberg-Kimmel Institute for Cancer Immunotherapy (V. Anagnostou, P. Forde, J. Brahmer, D. Pardoll, V. Velculescu), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (V. Velculescu), the Eastern Cooperative Oncology Group- American College of Radiology Imaging Network (V. Anagnostou), MacMillan Foundation (V. Anagnostou), the V Foundation (V. Anagnostou, V. Velculescu), the ICTR-ATIP UL1TR001079 (V. Anagnostou), the Pardee Foundation (V. Anagnostou), Swim Across America (V. Anagnostou), the William R. Brody Faculty Scholarship (R.Karchin), the SU2C-ACS Lung Cancer Dream Team (P. Forde and E. Gabrielson), PRIME Oncology (J. Naidoo), the MSK Cancer Center Support Grant/Core Grant (P30 CA008747), the SU2C DCS International Translational Cancer Research Dream Team Grant (SU2C-AACR-DT1415; V. Velculescu), the SU2C-LUNGevity-American Lung Association Lung Cancer Interception Dream Team (J. Brahmer, V. Velculescu), the Allegheny Health Network &#8211; Johns Hopkins Research Fund (V. Anagnostou, V. Velculescu), the LUNGevity Foundation (V. Anagnostou and P. Forde), the Mark Foundation (A. Leal, V. Velculescu), and Bristol Meyers Squibb (P. Forde). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. This publication was made possible in part by the Johns Hopkins Institute for Clinical and Translational Research (ICTR), which is funded in part by Grant Number UL1TR001079 from the National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS or NIH.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="3341" CGType="cg_class_HMB" title="Health/Medical/Biomedical (IRB, NPU)" name="HMB-IRB-NPU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="Yes"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the data is limited to not-for-profit organizations.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="14" name="completed_by_gpa" title="Completed by GPA"/></Study></dbgapss>